[Congressional Record Volume 167, Number 92 (Wednesday, May 26, 2021)]
[Senate]
[Pages S3492-S3496]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
ENDLESS FRONTIER ACT--Continued
Amendment No. 1588 to Amendment No. 1502
Mr. COONS. Mr. President, I rise to call up my amendment No. 1588,
which is cosponsored by Senators Graham and Lujan, Barrasso, and
Collins.
This amendment would establish a Foundation for Energy Security and
Innovation, a nonprofit Foundation to support the Department of
Energy's mission to help raise private capital to accelerate the
commercialization of new and cutting-edge technologies.
As China has dramatically ramped up their R&D funding, our Federal
funding has remained stagnant, threatening U.S. competitiveness and our
potential to develop, bring to scale, and export clean energy
technologies.
This amendment will take a model already proven by Foundations
affiliated with the NIH, the CDC, the Department of Agriculture, and
create a Foundation to channel private sector investments into our
world-class scientific innovation institutions, our National Labs.
This new Foundation would support the great work already happening at
[[Page S3493]]
the Department of Energy by leveraging public-private partnerships to
address tech transfer barriers.
Working on this bill over the years, I have heard significant
interest from the private sector and philanthropists looking for an
entity to coordinate their investment.
This bipartisan and bicameral bill passed the House last year with
the leadership of now Senator Lujan, and I urge my colleagues to
support its passage.
I want to thank my partners, Senators Graham and Lujan, for their
leadership and thank Senators Barrasso and Collins for cosponsoring,
Senators Schumer and Manchin for their support, and Senators Wicker,
Cantwell, and Young for their leadership on the Endless Frontier Act.
I yield the floor.
The PRESIDING OFFICER. The clerk will report the amendment by number.
The senior assistant legislative clerk read as follows:
The Senator from Delaware [Mr. Coons] proposes an amendment
numbered 1588 to amendment No. 1502.
(The amendment is printed in the Record of May 19, 2021 under ``Text
of Amendments.'')
Vote on Amendment No. 1588
The PRESIDING OFFICER. The question is on agreeing to the amendment.
Mr. COONS. Mr. President, I ask for the yeas and nays.
The PRESIDING OFFICER. Is there a sufficient second?
There appears to be a sufficient second.
The clerk will call the roll.
The legislative clerk called the roll.
Mr. DURBIN. I announce that the Senator from West Virginia (Mr.
Manchin) is necessarily absent.
Mr. THUNE. The following Senators are necessarily absent: the Senator
from Tennessee (Mrs. Blackburn) and the Senator from North Carolina
(Mr. Tillis).
The PRESIDING OFFICER (Ms. Baldwin). Are there any other Senators in
the Chamber desiring to vote?
The result was announced--yeas 83, nays 14, as follows:
[Rollcall Vote No. 210 Leg.]
YEAS--83
Baldwin
Barrasso
Bennet
Blumenthal
Blunt
Booker
Boozman
Braun
Brown
Burr
Cantwell
Capito
Cardin
Carper
Casey
Cassidy
Collins
Coons
Cornyn
Cortez Masto
Cotton
Cramer
Daines
Duckworth
Durbin
Ernst
Feinstein
Fischer
Gillibrand
Graham
Grassley
Hassan
Heinrich
Hickenlooper
Hirono
Hoeven
Hyde-Smith
Inhofe
Kaine
Kelly
Kennedy
King
Klobuchar
Lankford
Leahy
Lujan
Markey
McConnell
Menendez
Merkley
Moran
Murkowski
Murphy
Murray
Ossoff
Padilla
Peters
Portman
Reed
Romney
Rosen
Rounds
Rubio
Sanders
Sasse
Schatz
Schumer
Scott (SC)
Shaheen
Sinema
Smith
Stabenow
Sullivan
Tester
Thune
Van Hollen
Warner
Warnock
Warren
Whitehouse
Wicker
Wyden
Young
NAYS--14
Crapo
Cruz
Hagerty
Hawley
Johnson
Lee
Lummis
Marshall
Paul
Risch
Scott (FL)
Shelby
Toomey
Tuberville
NOT VOTING--3
Blackburn
Manchin
Tillis
The PRESIDING OFFICER. On this vote, the yeas are 83, the nays are
14.
Under the previous order requiring 60 votes for the adoption of this
amendment, the amendment is agreed to.
The amendment (No. 1588) was agreed to.
Amendment No. 1929 to Amendment No. 1502
Mr. LEE. Madam President, I call up my amendment No. 1929 and ask
that it be reported by number.
The PRESIDING OFFICER. The clerk will report the amendment by number.
The senior assistant legislative clerk read as follows:
The Senator from Utah [Mr. Lee] proposes an amendment
numbered 1929 to amendment No. 1502.
(The amendment is printed in the Record of May 24, 2021, under ``Text
of Amendments.'')
The PRESIDING OFFICER. There are now 2 minutes of debate, equally
divided, on the amendment.
The Senator from Utah.
Mr. LEE. Madam President, the United States of America cannot
meaningfully compete with Communist China. If our own government and if
our own Federal regulatory system, one that 25 years ago was costing
the American economy $300 billion a year and is now costing the
American economy $2 trillion, if that regulatory system is hobbling us,
we won't be able to compete.
That is why I introduced this amendment No. 1929, to bring the focus
of the debate back to where it belongs--back to our regulatory
challenges. It sets up a Regulatory Oversight and Review Task Force,
composed of OMB, OIRA, and people in the private sector with expertise
in this area.
The bipartisan task force would have, as its job, to conduct annually
a review of all Federal regulations to figure out what is working, what
is not working, what is harming American job growth, and what is
helping.
Congress would then have the opportunity to review these
recommendations and review recommendations in a way that would
ultimately bring about regulatory reform helping us to compete with
Communist China.
We can't beat China at its own game. We have to beat China by being
our best selves. That is what amendment 1929 will do.
The PRESIDING OFFICER. The Senator from Michigan.
Mr. PETERS. Madam President, this measure undermines Federal
Agencies' efforts to protect workers, consumers, our environment, and
public health. When Federal Agencies create regulations, they must look
at the full range of costs and benefits, including the impact on
employers, workers, and vulnerable groups.
This measure shuts out most of these voices. It is designed to push
Congress to repeal regulations without considering the concerns of
workers who rely on Federal safety standards or communities whose water
has been polluted by lead.
If Congress is concerned about a regulation, we already have tools to
make the needed changes--either passing a law or using procedures like
the Congressional Review Act. We need to move forward on bipartisan
policies that will improve our Nation's competitiveness, not measures
that will endanger our constituents and our communities. I urge my
colleagues to vote no on amendment 1929.
Vote on Amendment No. 1929
Mr. LEE. I ask for the yeas and nays.
The PRESIDING OFFICER. The question is on agreeing to the amendment.
Is there a sufficient second?
Mr. DURBIN. Madam President.
The PRESIDING OFFICER. The Democratic whip.
Mr. DURBIN. Madam President, I ask unanimous consent the remaining
votes tonight be 10-minute votes.
The PRESIDING OFFICER. Without objection, it is so ordered.
Is there a sufficient second?
There appears to be a sufficient second.
The clerk will call the roll.
The senior assistant legislative clerk called the roll.
Mr. DURBIN. I announce that the Senator from West Virginia (Mr.
Manchin) is necessarily absent.
Mr. THUNE. The following Senators are necessarily absent: the Senator
from Tennessee (Mrs. Blackburn) and the Senator from North Carolina
(Mr. Tillis).
The PRESIDING OFFICER. Are there any other Senators in the Chamber
desiring to vote?
The result was announced--yeas 48, nays 49, as follows:
[Rollcall Vote No. 211 Leg.]
YEAS--48
Barrasso
Blunt
Boozman
Braun
Burr
Capito
Cassidy
Collins
Cornyn
Cotton
Cramer
Crapo
Cruz
Daines
Ernst
Fischer
Graham
Grassley
Hagerty
Hawley
Hoeven
Hyde-Smith
Inhofe
Johnson
Kennedy
Lankford
Lee
Lummis
Marshall
McConnell
Moran
Murkowski
Paul
Portman
Risch
Romney
Rounds
Rubio
Sasse
Scott (FL)
Scott (SC)
Shelby
Sullivan
Thune
Toomey
Tuberville
Wicker
Young
NAYS--49
Baldwin
Bennet
Blumenthal
Booker
Brown
Cantwell
Cardin
Carper
Casey
[[Page S3494]]
Coons
Cortez Masto
Duckworth
Durbin
Feinstein
Gillibrand
Hassan
Heinrich
Hickenlooper
Hirono
Kaine
Kelly
King
Klobuchar
Leahy
Lujan
Markey
Menendez
Merkley
Murphy
Murray
Ossoff
Padilla
Peters
Reed
Rosen
Sanders
Schatz
Schumer
Shaheen
Sinema
Smith
Stabenow
Tester
Van Hollen
Warner
Warnock
Warren
Whitehouse
Wyden
NOT VOTING--3
Blackburn
Manchin
Tillis
The PRESIDING OFFICER. On this vote, the yeas are 48, the nays are
49.
Under the previous order requiring 60 votes for adoption of this
amendment, the amendment is not agreed to.
The amendment (No. 1929) was rejected.
The PRESIDING OFFICER. The Senator from Indiana.
Amendment No. 1771 to Amendment No. 1502
Mr. BRAUN. Madam President, I call up my amendment No. 1771 and ask
that it be reported by number.
The PRESIDING OFFICER. The clerk will report.
The bill clerk read as follows:
The Senator from Indiana [Mr. Braun] proposes an amendment
numbered 1771 to amendment No. 1502.
The amendment is as follows
(Purpose: To amend title 18, United States Code, to prohibit certain
types of human-animal chimeras)
At the appropriate place, insert the following:
SEC. __. PROHIBITION ON CERTAIN HUMAN-ANIMAL CHIMERAS.
(a) In General.--Part I of title 18, United States Code, is
amended by inserting after chapter 51 the following:
``CHAPTER 52--CERTAIN TYPES OF HUMAN-ANIMAL CHIMERAS PROHIBITED
``Sec.
``1131. Definitions.
``1132. Prohibition on human-animal chimeras.
``Sec. 1131. Definitions
``In this chapter:
``(1) Human embryo.--The term `human embryo' means an
organism of the species Homo sapiens during the earliest
stages of development, from 1 cell up to 8 weeks after
conception.
``(2) Prohibited human-animal chimera.--The term
`prohibited human-animal chimera' means--
``(A) a human embryo into which a nonhuman cell or cells
(or the component parts thereof) have been introduced to
render the embryo's membership in the species Homo sapiens
uncertain;
``(B) a human-animal embryo produced by fertilizing a human
egg with nonhuman sperm;
``(C) a human-animal embryo produced by fertilizing a
nonhuman egg with human sperm;
``(D) an embryo produced by introducing a nonhuman nucleus
into a human egg;
``(E) an embryo produced by introducing a human nucleus
into a nonhuman egg;
``(F) an embryo containing at least haploid sets of
chromosomes from both a human and a nonhuman life form;
``(G) a nonhuman life form engineered such that human
gametes develop within the body of a nonhuman life form;
``(H) a nonhuman life form engineered such that it contains
a human brain or a brain derived wholly or predominantly from
human neural tissues;
``(I) nonhuman life form engineered such that it exhibits
human facial features or other bodily morphologies to
resemble human features; or
``(J) an embryo produced by mixing human and nonhuman
cells, such that--
``(i) human gametes develop within the body of the
resultant organism;
``(ii) it contains a human brain or a brain derived wholly
or predominantly from human neural tissues; or
``(iii) it exhibits human facial features or other bodily
morphologies to resemble human features.
``Sec. 1132. Prohibition on certain human-animal chimeras
``(a) In General.--It shall be unlawful for any person to
knowingly, in or otherwise affecting interstate commerce--
``(1) create or attempt to create a prohibited human-animal
chimera;
``(2) transfer or attempt to transfer a human embryo into a
nonhuman womb;
``(3) transfer or attempt to transfer a nonhuman embryo
into a human womb; or
``(4) transport or receive for any purpose a prohibited
human-animal chimera.
``(b) Penalties.--
``(1) In general.--Whoever violates subsection (a) shall be
fined under this title, imprisoned not more than 10 years, or
both.
``(2) Civil penalty.--Whoever violates subsection (a) shall
be subject to a civil fine of the greater of--
``(A) $1,000,000; or
``(B) the amount equal to twice the amount of the gross
pecuniary gain, if any.
``(c) Rule of Construction.--This section does not prohibit
research involving the use of transgenic animal models
containing human genes or transplantation of human organs,
tissues, or cells into recipient animals, if such activities
are not prohibited under subsection (a).''.
(b) Technical Amendment.--The table of chapters for part I
of title 18, United States Code, is amended by inserting
after the item relating to chapter 51 the following:
``52. Certain types of human-animal chimeras prohibited1131.''.........
Mr. BRAUN. Madam President, in recent years, research involving
human-animal hybrids has become much more prevalent. For example, in
April, researchers in China created a monkey-human hybrid embryo that
they allowed to grow and studied for weeks.
I have serious ethical concerns with this type of human chimera
research. My amendment would ban the practice by applying the NIH's
current anti-chimera policy universally.
Due to the dangerous and offensive nature of this research, my
amendment imposes penalties on those who participate in this unethical
research.
We must act now. Just this morning, the International Society for
Stem Cell Research, an international standards-setting body, issued
guidance that permits the creation of human-animal hybrids. I ask that
my Senate colleagues reject this foreign position and maintain our own
NIH's ethical standards.
All life is sacred. It is Congress's responsibility to enact
commonsense bioethics.
The PRESIDING OFFICER. The Senator's time has expired.
Mr. BRAUN. Please support this amendment.
The PRESIDING OFFICER. The senior Senator from Washington.
Mrs. MURRAY. Madam President, I was just here yesterday reminding my
colleagues that this is a bipartisan bill to help families across our
country by boosting American's competitiveness. I have said it already.
I will say it again. That means we have to ensure that American
research is guided by science, not ideology.
This amendment does the exact opposite and undermines scientifically
significant research that could actually help develop new treatments
and ultimately lead to lifesaving organ transplants.
If we are serious about bipartisan commitment to American innovation,
we have to stop these ideological attacks on medical research and focus
on the science and ultimately the health of our patients.
I urge a ``no'' vote. Thank you.
Vote on Amendment No. 1771
The PRESIDING OFFICER. The question is on agreeing to the amendment.
Mr. BRAUN. I ask for the yeas and nays.
The PRESIDING OFFICER. Is there a sufficient second?
There appears to be a sufficient second.
The clerk will call the roll.
The bill clerk called the roll.
Mr. DURBIN. I announce that the Senator from West Virginia (Mr.
Manchin) is necessarily absent.
Mr. THUNE. The following Senators are necessarily absent: the Senator
from Tennessee (Mrs. Blackburn) and the Senator from North Carolina
(Mr. Tillis).
The PRESIDING OFFICER. Are there any other Senators in the Chamber
desiring to vote or change their vote?
The result was announced--yeas 48, nays 49, as follows:
[Rollcall Vote No. 212 Leg.]
YEAS--48
Barrasso
Blunt
Boozman
Braun
Burr
Capito
Cassidy
Collins
Cornyn
Cotton
Cramer
Crapo
Cruz
Daines
Ernst
Fischer
Graham
Grassley
Hagerty
Hawley
Hoeven
Hyde-Smith
Inhofe
Johnson
Kennedy
Lankford
Lee
Lummis
Marshall
McConnell
Moran
Murkowski
Paul
Portman
Risch
Romney
Rounds
Rubio
Sasse
Scott (FL)
Scott (SC)
Shelby
Sullivan
Thune
Toomey
Tuberville
Wicker
Young
NAYS--49
Baldwin
Bennet
Blumenthal
Booker
Brown
Cantwell
Cardin
Carper
Casey
Coons
Cortez Masto
Duckworth
Durbin
Feinstein
Gillibrand
Hassan
Heinrich
Hickenlooper
Hirono
Kaine
Kelly
King
Klobuchar
Leahy
Lujan
Markey
Menendez
Merkley
Murphy
Murray
Ossoff
Padilla
Peters
Reed
Rosen
Sanders
Schatz
Schumer
Shaheen
Sinema
Smith
Stabenow
Tester
[[Page S3495]]
Van Hollen
Warner
Warnock
Warren
Whitehouse
Wyden
NOT VOTING--3
Blackburn
Manchin
Tillis
The PRESIDING OFFICER. On this vote, the yeas are 48, the nays are
49.
Under the previous order requiring 60 votes for the adoption of this
amendment, the amendment is rejected.
The amendment (No. 1771) was rejected.
The junior Senator from Kansas.
Amendment No. 1973, as Modified, to Amendment No. 1502
Mr. MARSHALL. Madam President, I call up my amendment No. 1973, as
modified, with the changes at the desk and ask that it be reported by
number.
The PRESIDING OFFICER. The clerk will report the amendment.
The senior assistant legislative clerk read as follows:
The Senator from Kansas [Mr. Marshall] proposes an
amendment numbered 1973, as modified, to amendment No. 1502.
The amendment, as modified, is as follows
(Purpose: To express the sense of the Senate regarding the need to
conduct a comprehensive investigation to determine the origins of
COVID-19, and for other purposes)
At the appropriate place, insert the following:
SEC. ____. FINDINGS AND SENSE OF THE SENATE REGARDING AN
INVESTIGATION TO DETERMINE THE ORIGINS OF
COVID-19.
(a) Findings.--Congress finds the following:
(1) COVID-19 has taken the lives of nearly 3,500,000
individuals around the world.
(2) Understanding the origins of the COVID-19 pandemic is
essential to addressing our vulnerabilities and preventing
future crises.
(3) In May 2020, the World Health Assembly did not
authorize a comprehensive investigation into the origins of
COVID-19, and instead passed a significantly limited
compromise resolution, with Chinese government support, which
did not explicitly include in its scope the possibility of a
research-related accident.
(4) The 2020 World Health Assembly resolution and its terms
of reference, which were negotiated privately between the
World Health Organization (in this section referred to as
``WHO'') and Chinese authorities, handed the Chinese
government control over the joint-study process by giving the
Chinese government veto power over which international
experts were allowed to participate in the joint study and by
agreeing that most primary research would be carried out by
Chinese teams without ensuring broad access to primary data
by international experts.
(5) As a result of these terms, the significant structural,
procedural, and analytical shortcomings of the joint study,
and the severe restrictions imposed by Chinese authorities,
the WHO-convened joint study into the origins of COVID-19 was
prevented from providing a balanced consideration of the
multiple theories of the origin of COVID-19.
(6) Only 4 of the 313 pages of the joint-study team report
and its annexes addressed the possibility of a laboratory
accident, and no thorough examination of the lab incident
hypothesis was carried out by the joint-study team.
(7) Some of the international experts on the joint-study
team stated that they lacked the means and resources to
properly investigate the research-related accident
hypothesis, and they were neither able nor meant to do such a
full investigation but instead were acting as a ``study
review group''.
(8) WHO Director-General Dr. Tedros Adhanom Ghebreyesus
commented on March 30, 2021, the day the joint-study report
was released, ``I do not believe that [the joint-study
team's] assessment [of a possible lab incident] was extensive
enough. Further data and studies will be needed to reach more
robust conclusions . . . potentially with additional missions
involving specialist experts, which I am ready to deploy.''.
(9) The WHO Director-General further commented, ``As far as
WHO is concerned all hypotheses remain on the table . . . We
have not yet found the source of the virus, and we must
continue to follow the science and leave no stone unturned as
we do . . . It is clear that we need more research across a
range of areas, which will entail further field visits.''.
(10) The March 30, 2021 Joint Statement on the WHO-convened
COVID-19 Origins Study by the United States and 13 other
countries recognized the severe shortcomings of the joint-
study process and called for ``a transparent and independent
analysis and evaluation, free from interference and undue
influence.''.
(11) In spite of the devastation the COVID-19 pandemic has
caused in the United States and around the world, no process
currently exists to ensure a comprehensive investigation into
the source of COVID-19.
(12) Such an investigation is essential for ensuring this
type of crisis never happens again for the benefit of all
people, all nations, and future generations.
(b) Sense of the Senate.--It is the sense of the Senate
that--
(1) a comprehensive investigation to determine the origins
of COVID-19 must be conducted by WHO immediately, with access
to all relevant records, samples, and personnel in China, and
that such investigation must fully explore all possible
sources of the COVID-19 pandemic, including exclusively
``natural'' zoonosis in the wild, human contamination in an
animal farm, and a research-related accident;
(2) the United States delegation to the World Health
Assembly should, in concert with allies and partners around
the world, work to ensure that an international scientific
investigation into the origins of COVID-19, with full access
to all relevant records, samples, and personnel in China,
will be authorized by the World Health Assembly and
implemented with extreme urgency; and
(3) should such a full investigation not be authorized by
the 2021 World Health Assembly, then the United States
Government should immediately begin planning a comprehensive
and data-driven investigation into the COVID-19 pandemic
origins, in concert with willing partner governments and
experts around the world.
The PRESIDING OFFICER. There are now 2 minutes of debate, equally
divided, on the amendment.
Mr. MARSHALL. Madam President, over the past year, COVID-19 has
spread to all corners of the world, killing more than 3 million people
in its path, including more than 550,000 Americans. We were originally
told this virus initiated in a wet market or that it may have come from
a bat that directly infected a human. However, the preponderance of
evidence now suggests this virus may have leaked from a lab in Wuhan.
With the World Health Assembly meeting this week, I ask this body to
fully express support for a complete investigation into this outbreak.
It is outrageous and inconceivable that a comprehensive investigation
has still not occurred.
If China continues on its path of coverup, we must begin planning a
full investigation, including with partners around the world. It would
be utterly irresponsible to suffer through the worst pandemic in a
century and not have the origins fully investigated.
Our bipartisan amendment will deliver the message that the Chinese
must show us the data and be transparent with the world, and if they
don't, we will fight to get to the bottom of this pandemic.
I thank Senator Gillibrand for introducing this amendment with me and
ask that all Senators join us in approving it, and we hope, we believe,
that this can pass with a voice vote.
Thank you. And I yield.
Mrs. GILLIBRAND. Mr. President, I yield back all time, and I support
this amendment.
The PRESIDING OFFICER. Without objection, all time is yielded back.
Vote on Amendment No. 1973
Ms. CANTWELL. Madam President, I ask unanimous consent to vitiate the
60-vote threshold for this amendment.
The PRESIDING OFFICER. Is there objection?
Without objection, it is so ordered.
The question is on agreeing to the amendment.
The amendment (No. 1973), as modified, was agreed to.
The PRESIDING OFFICER. The Senator from Nebraska.
Amendment No. 2023 to Amendment No. 1502
Mr. SASSE. Madam President, I would like to call up my amendment No.
2023 and ask that it be reported by number.
The PRESIDING OFFICER. The clerk will report the amendment by number.
The bill clerk read as follows:
The Senator from Nebraska [Mr. Sasse] proposes amendment
numbered 2023 to amendment No. 1502.
The amendment is as follows
(Purpose: To authorize appropriations for the Defense Advanced Research
Projects Agency to conduct research and development in key technology
focus areas)
At the appropriate place in division B, insert the
following:
SEC. ___. AUTHORIZATION OF APPROPRIATIONS FOR THE DEFENSE
ADVANCED RESEARCH PROJECTS AGENCY.
(a) In General.--Notwithstanding any other provision of
law, there is authorized to be appropriated for the Defense
Advanced Research Projects Agency to conduct research and
development in key technology focus areas $3,500,000,000 for
each of fiscal years 2022 through 2026.
(b) Supplement, Not Supplant.--Any amount appropriated
pursuant to the authorization in subsection (a) shall
supplement and not supplant any amounts already appropriated
for the Defense Advanced Research Projects Agency.
[[Page S3496]]
The PRESIDING OFFICER. The Senator from Nebraska.
Mr. SASSE. Madam President, my amendment about doubling DARPA funding
is really simple: It doubles DARPA funding. This amendment would
provide an additional $3.5 billion a year to the base, $3.5 billion
that DARPA currently receives over the next 5 years.
To members of the Armed Services Committee, I would tell you, this
amendment doesn't do anything to mess with your base authorization.
Your work is not displaced. This is simply additive. Modern war isn't
just about enemy landings; it is also about enemy hackings. And the
Chinese Communist Party is currently pouring money into machine
learning, AI, and quantum because they think if they achieve first-
mover advantage in cyber, they will ultimately become the world's
preeminent superpower. DARPA's job is to make sure that doesn't happen.
We to need to make sure that Chairman Xi lies awake at night worrying
about his critical infrastructure, his networks, and his
vulnerabilities. And DARPA is currently doing that work, but DARPA is
not funded for us to win the technology race.
Money that goes to NSF, which is the core of the bill that is before
us----
The PRESIDING OFFICER. The Senator's time has expired.
Mr. SASSE (continuing). Is important, but DARPA is different. DARPA
is the one that leads Chairman Xi to be worried at night.
I request a ``yes'' vote.
The PRESIDING OFFICER. Who yields time?
Mr. SASSE. I ask for a recorded vote, and I ask for the yeas and
nays.
Vote on Amendment No. 2023
The PRESIDING OFFICER. The question is on agreeing to the amendment.
Is there a sufficient second?
There is a sufficient second.
The clerk will call the roll.
The senior assistant legislative clerk called the roll.
Mr. DURBIN. I announce that the Senator from West Virginia (Mr.
Manchin) is necessarily absent.
Mr. THUNE. The following Senators are necessarily absent: the Senator
from Tennessee (Mrs. Blackburn) and the Senator from North Carolina
(Mr. Tillis).
The PRESIDING OFFICER. Are there any other Senators in the Chamber
desiring to vote?
The result was announced--yeas 67, nays 30, as follows:
[Rollcall Vote No. 213 Leg.]
YEAS--67
Barrasso
Bennet
Blumenthal
Blunt
Boozman
Burr
Cantwell
Capito
Casey
Collins
Coons
Cornyn
Cortez Masto
Cotton
Cramer
Cruz
Daines
Durbin
Ernst
Fischer
Gillibrand
Graham
Hagerty
Hassan
Heinrich
Hickenlooper
Hoeven
Hyde-Smith
Inhofe
Kaine
Kelly
Kennedy
King
Lujan
Marshall
McConnell
Moran
Murkowski
Murphy
Murray
Ossoff
Padilla
Peters
Portman
Romney
Rosen
Rounds
Rubio
Sasse
Schatz
Schumer
Scott (FL)
Scott (SC)
Shaheen
Shelby
Sinema
Stabenow
Sullivan
Tester
Thune
Van Hollen
Warner
Warnock
Warren
Whitehouse
Wicker
Young
NAYS--30
Baldwin
Booker
Braun
Brown
Cardin
Carper
Cassidy
Crapo
Duckworth
Feinstein
Grassley
Hawley
Hirono
Johnson
Klobuchar
Lankford
Leahy
Lee
Lummis
Markey
Menendez
Merkley
Paul
Reed
Risch
Sanders
Smith
Toomey
Tuberville
Wyden
NOT VOTING--3
Blackburn
Manchin
Tilli
The PRESIDING OFFICER. On this vote, the yeas are 67, the nays are
30.
Under the previous order requiring 60 votes for the adoption of this
amendment, the amendment is agreed to.
The amendment (No. 2023) was agreed to.
The PRESIDING OFFICER. The majority leader.
____________________